VIDEO From and AstraZeneca: AstraZeneca Announces Third Quarter and Nine Months Results 2010

Oct 28, 2010, 04:48 ET from from ,AstraZeneca

NEW YORK, Oct. 28 /PRNewswire/ -- See video from AstraZeneca at:

Anglo-Swedish pharmaceutical company AstraZeneca announced that revenue for the third quarter declined by 2% at constant exchange rates (CER) to $7,898 million. Strong double-digit sales growth at CER for Crestor, Symbicort and Seroquel XR. Revenue in markets outside the US increased by 7% at CER, including a 14% increase in Emerging Markets.

As expected, revenue in the US was affected by generic competition for Arimidex, Pulmicort Respules and Toprol-XL, as well as the absence of H1N1 pandemic influenza vaccine revenue that benefited the third quarter 2009. US revenue was down 13% in the third quarter. Available video includes headquarters, laboratory and production shots

About delivers free broadcast- and streaming-quality video and multimedia content directly to media around the world, 24/7. More than 25,000 media outlets in 190+ countries use, including the AP, BBC, CNBC, CNN, France 24, N24,, RAI, TVE and ZDF.  

Registered journalists can access video, audio, text, graphics and photos at

If you are not already registered, please take a moment to sign up - registration is quick and free:

Story Id: 20226

SOURCE; AstraZeneca